151 related articles for article (PubMed ID: 34498363)
1. Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer.
Karaca S; Koca T; Sarpün İH; Tunçel N; Korcum Şahin AF
J Appl Clin Med Phys; 2021 Oct; 22(10):136-143. PubMed ID: 34498363
[TBL] [Abstract][Full Text] [Related]
2. Compared planning dosimetry of TOMO, VMAT and IMRT in rectal cancer with different simulated positions.
Lin JC; Tsai JT; Chen LJ; Li MH; Liu WH
Oncotarget; 2017 Jun; 8(26):42020-42029. PubMed ID: 28159930
[TBL] [Abstract][Full Text] [Related]
3. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
4. Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang Y; Xiao Q; Zeng B; Ni Q; Liu X; Liu X; Tian L; Sheng C; Peng L; Wang H
Med Dosim; 2020 Spring; 45(1):e6-e12. PubMed ID: 31176536
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma.
Zhang Y; Wang H; Huang X; Zhang Q; Ren R; Sun R; Zheng Z; Dong S; Zheng A
Med Dosim; 2019 Summer; 44(2):167-172. PubMed ID: 29950277
[TBL] [Abstract][Full Text] [Related]
6. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mixed energy partial arcs for volumetric modulated arc therapy for prostate cancer.
Momin S; Gräfe JL; Khan RF
J Appl Clin Med Phys; 2019 Apr; 20(4):51-65. PubMed ID: 30861308
[TBL] [Abstract][Full Text] [Related]
8. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
11. Treatment planning comparison between dynamic wave arc and volumetric modulated arc therapies for prostate-cancer treatment.
Miura H; Nakao M; Doi Y; Ozawa S; Kenjo M; Nagata Y
Med Dosim; 2022 Spring; 47(1):48-53. PubMed ID: 34538693
[TBL] [Abstract][Full Text] [Related]
12. Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy.
Shen Y; Tang X; Lin S; Jin X; Ding J; Shao M
Med Phys; 2024 Jan; 51(1):545-555. PubMed ID: 37748133
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a hybrid automatic planning solution for rectal cancer.
Peng J; Yu L; Xia F; Zhang K; Zhang Z; Wang J; Hu W
Radiat Oncol; 2022 Oct; 17(1):166. PubMed ID: 36229849
[TBL] [Abstract][Full Text] [Related]
14. Dominant intraprostatic lesion boosting in sexual-sparing radiotherapy of prostate cancer: A planning feasibility study.
Ciabatti S; Ntreta M; Buwenge M; Gaudiano C; Sessagesimi E; Romani F; Angelini AL; Cammelli S; Macchia G; Deodato F; Zamagni A; Golfieri R; Morganti AG; Cilla S
Med Dosim; 2019 Winter; 44(4):356-364. PubMed ID: 30955990
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract][Full Text] [Related]
16. High-precision radiotherapy for craniospinal irradiation: evaluation of three-dimensional conformal radiotherapy, intensity-modulated radiation therapy and helical TomoTherapy.
Sharma DS; Gupta T; Jalali R; Master Z; Phurailatpam RD; Sarin R
Br J Radiol; 2009 Dec; 82(984):1000-9. PubMed ID: 19581313
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
18. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of robust optimization against geometric uncertainties in TomoHelical planning for prostate cancer.
Yagihashi T; Inoue K; Nagata H; Yamanaka M; Yamano A; Suzuki S; Yamakabe W; Sato N; Omura M; Inoue T
J Appl Clin Med Phys; 2023 Apr; 24(4):e13881. PubMed ID: 36576418
[TBL] [Abstract][Full Text] [Related]
20. Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy.
Wang X; Tian Y; Tang Y; Hu ZH; Zhang JJ; Fu GS; Ma P; Ren H; Zhang T; Li N; Liu WY; Fang H; Li YX; Jin J
Oncotarget; 2017 Jun; 8(24):39727-39735. PubMed ID: 28061474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
